Abstract
The human hepatoma cell line, PLC/PRF/5, was shown to produce hepatitis B surface antigen (HBsAg). Immunologically reactive material was present in the supernatant tissue culture medium in significant amounts, and was associated with spherical particles approximately 20 nm in diameter. The rate of antigen production by the cells was estimated at 500 ng/day/10(6) cells by reference to a purified HBsAg standard. All immunological activity was neutralized by specific antibody and the subtype was ad. The studies reported here broaden the scope of investigations on both the in vitro production of HBsAg and the association between this antigen and primary liver cancer.
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
MacNab, G., Alexander, J., Lecatsas, G. et al. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 34, 509–515 (1976). https://doi.org/10.1038/bjc.1976.205
Issue Date:
DOI: https://doi.org/10.1038/bjc.1976.205
- Springer Nature Limited
This article is cited by
-
DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas
Journal of Cancer Research and Clinical Oncology (2023)
-
Establishment and characterization of a new Chinese hepatocellular carcinoma cell line, Hep-X1
Human Cell (2022)
-
The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells
Scientific Reports (2021)
-
Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma
Oncogene (2021)
-
Use of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals?
Archives of Toxicology (2018)